Commentary Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties

, , , , , , , , , , , , , , , , , , , , , and | January 9th 2020

 -

The guidelines provide a framework to perform a BRA to justify the presence of CMR or ED phthalates in medical devices.
They also describe the evaluation of possible alternatives for these phthalates used in medical devices.
Manufacturers are encouraged to generate data that are needed for the BRA on potential alternatives to be used in medical devices.
GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties

, , , , , , , , , , , , and | December 16th 2019

 -

The Scientific Committee on Health, Environmental and Emerging Risks of the European Commission adopted this document at plenary meeting on 18 June 2019.
NIOM Scientist and Head of Laboratory, Hilde M. Kopperud served as external expert.
Are LED Lights a Hazard to Human Health?

August 22nd 2018

 -

There is no evidence that the general public is at risk of direct adverse health effects from Light Emitting Diodes (LEDs) when the lights (lamps for lighting and displays) are in normal use, the European Commission stated in a recent published Opinion. The Scienti c Committee on Health, Environmental and Emerging Risks (SCHEER), having a NIOM scientist as expert member, authored the Opinion.
SCHEER: Preliminary Opinion on the potential risks to human health of Light Emitting Diodes (LEDs)

, , , , , , , and | October 18th 2017

 -

The Scientific Committee on Health, Environmental and Emerging Risks of the European Commission released the Preliminary Opinion in July. The Opinion was open for comments until September. NIOM scientist, Ellen Bruzell, served as external expert in the preparation of the Preliminary Opinion.